Allogene Therapeutics, Inc.ALLONASDAQ
Loading
Year-over-year operating income growth rate
Latest
5.56%
↑ 100% vs avg
Percentile
P72
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-4088.67%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 5.56% |
| Q3 2025 | 20.98% |
| Q2 2025 | 12.84% |
| Q1 2025 | -7.77% |
| Q4 2024 | 15.72% |
| Q3 2024 | -0.48% |
| Q2 2024 | -2.77% |
| Q1 2024 | 18.40% |
| Q4 2023 | -35.21% |
| Q3 2023 | 21.78% |
| Q2 2023 | 18.72% |
| Q1 2023 | -2.82% |
| Q4 2022 | -16.83% |
| Q3 2022 | -7.70% |
| Q2 2022 | 4.25% |
| Q1 2022 | -8.25% |
| Q4 2021 | 4.86% |
| Q3 2021 | -9.35% |
| Q2 2021 | -113.94% |
| Q1 2021 | 52.13% |
| Q4 2020 | -1.94% |
| Q3 2020 | -7.73% |
| Q2 2020 | -9.49% |
| Q1 2020 | 10.67% |
| Q4 2019 | -17.39% |
| Q3 2019 | -19.69% |
| Q2 2019 | -26.06% |
| Q1 2019 | -10.33% |
| Q4 2018 | -48.94% |
| Q3 2018 | 83.57% |
| Q2 2018 | -5098.77% |
| Q1 2018 | -129750.00% |
| Q4 2017 | 0.00% |